FDA Drug Recalls

Recalls / Class II

Class IID-0346-2022

Product

Perrigo Fexofenadine Hydrochloride tablets, 12HR, 60mg Antihistamine, 100 count bottle, Made in the Czech Republic, Distributed by Perrigo Allergan, MI 49010 NDC 45802-425-78 UPC 3 45802 425 78 2

Affected lot / code info
Lot# 0CR0510, Exp 09/30/21, 0GR0445, Exp 01/31/22, 0LR0361, Exp 04/30/22, 1AR0558 , Exp 07/31/22

Why it was recalled

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Recalling firm

Firm
Perrigo Company PLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
515 Eastern Ave, N/A, Allegan, Michigan 49010-9070

Distribution

Quantity
41,472 containers
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2021-07-27
FDA classified
2022-01-05
Posted by FDA
2022-01-12
Terminated
2022-11-08
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0346-2022. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.